Jessy Joy van Kleef

3PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 19, 2019
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).

Sandor Schokker, Stephanie O van der Woude, Jessy Joy van Kleef

|Feb 16, 2019
SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.

Héctor G van den Boorn, Ameen Abu-Hanna, Emil Ter Veer

|Jan 31, 2018
Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.

Emil Ter Veer, Jessy Joy van Kleef, Mirjam A G Sprangers

Pageof 1

Frequent Collaborators

3 joint publications

Héctor G van den Boorn

1 joint publications

Ameen Abu-Hanna

1 joint publications

Susan J Dutton

1 joint publications

Yung-Jue Bang